3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
122
Precursor Cell Lymphoblastic Leukemia-Lymphoma
108
Myelodysplastic Syndromes
97
Lymphoma, Non-Hodgkin
88
Leukemia, Lymphocytic, Chronic, B-Cell
81
Hodgkin Disease
81
Multiple Myeloma
80
Leukemia
72
Lymphoma, Mantle-Cell
62
Lymphoma, Follicular
58
Lymphoma
55
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
55
Myeloproliferative Disorders
52
Lymphoma, B-Cell, Marginal Zone
52
Lymphoma, Large B-Cell, Diffuse
48
Burkitt Lymphoma
48
Leukemia, Myelomonocytic, Chronic
47
Congenital Abnormalities
41
Hematologic Neoplasms
37
Lymphoma, Large-Cell, Immunoblastic
35
Leukemia, Myeloid, Accelerated Phase
34
Waldenstrom Macroglobulinemia
33
Leukemia, Myeloid, Chronic-Phase
33
Anemia, Refractory, with Excess of Blasts
32
Primary Myelofibrosis
31
Blast Crisis
28
Lymphoma, T-Cell, Cutaneous
27
Lymphoma, Large-Cell, Anaplastic
26
Leukemia, Biphenotypic, Acute
26
Dendritic Cell Sarcoma, Interdigitating
26
Interventions
Etoposide
7
pegaspargase
5
Methylprednisolone
4
Dexamethasone
4
Cyclophosphamide
3
Alemtuzumab
3
Gemcitabine
2
Doxorubicin
2
zanubrutinib
1
tocilizumab
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Th1-Th2 Balance
1
Tacrolimus
1
Rituximab
1
Prednisone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Melphalan
1
Flow Cytometry
1
EPOCH protocol
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphohistiocytosis, Hemophagocytic
×
Whole-Body Irradiation
×
Clear all
NCT00368355
2020-01-21
MOHEL
Baylor College of Medicine
Phase 2
Completed
46 enrolled
12 charts